However, it is unlikely that combining PD-L1+CTCs with the approved biomarkers TMB-H or MSI-H would have a predictive value, as multiple studies, based on tumor biopsy results, have demonstrated that PD-L1 is an independent biomarker from TMB-H or MSI-H [114,115,116,117]. Here, CD274 is linked to neoplasm.